Takeda Pharma ADR Earnings, Revenue miss In Q3

  • Investing.com
Takeda Pharma ADR Earnings, Revenue miss In Q3

Investing.com - Takeda Pharma ADR reported third quarter earnings that missed analysts' expectations on Thursday and revenue that fell short of forecasts.

The firm reported earnings per share of $0.01 on revenue of $7.56B. Analysts polled by Investing.com expected EPS of $0.15 on revenue of $7.81B. .

Takeda Pharma ADR follows other major sector earnings this month


On Tuesday, HSBC Holdings PLC ADR reported third quarter EPS of $0.21 on revenue of $12.07B, compared to forecasts of EPS of $0.24 on revenue of $12.09B.

Iberdrola SA earnings missed analyst's expectations on Wednesday, October 21, 2020, with third quarter EPS of $0.59 on revenue of $9.24B. Investing.com analysts expected EPS of $0.66 on revenue of $7.74B

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100